Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Pouya Azar"'
Autor:
Pouya Azar, Hannah Schneiderman, Henry Barron, James S. H. Wong, Maximilian Meyer, Dayyon Newman-Azar, Matin Narimani, Martha J. Ignaszewski, Nickie Mathew, Rodney Mullen, Reinhard M. Krausz, Anil R. Maharaj
Publikováno v:
Addiction Science & Clinical Practice, Vol 19, Iss 1, Pp 1-6 (2024)
Abstract Background Buprenorphine is an effective and safe treatment for opioid use disorder, but the requirement for moderate opioid withdrawal symptoms to emerge prior to initiation is a significant treatment barrier. Case Presentation We report on
Externí odkaz:
https://doaj.org/article/9f5e6efae8624acf90b6f7a23fce2bb1
Autor:
Vivian W. L. Tsang, James S.H. Wong, Jean N. Westenberg, Noor H. Ramadhan, Hasti Fadakar, Mohammadali Nikoo, Victor W. Li, Nick Mathew, Pouya Azar, Kerry L. Jang, Reinhard M. Krausz
Publikováno v:
Frontiers in Psychiatry, Vol 15 (2024)
ObjectivesFentanyl is a highly potent opioid and has, until recently, been considered an unwanted contaminant in the street drug supply among people who use drugs (PWUD). However, it has become a drug of choice for an increasing number of individuals
Externí odkaz:
https://doaj.org/article/1b006e1650c84f5dab429541b81cfc12
Autor:
Pouya Azar, Jean N. Westenberg, Martha J. Ignaszewski, James S. H. Wong, George Isac, Nickie Mathew, R. Michael Krausz
Publikováno v:
Addiction Science & Clinical Practice, Vol 17, Iss 1, Pp 1-6 (2022)
Abstract Background An increasing number of individuals who use drugs in North America are preferentially consuming fentanyl over other opioids. This has significant consequences on the treatment and management of opioid use disorder (OUD) and its co
Externí odkaz:
https://doaj.org/article/f303d2c09ac14a328ca1cbadac9227c6
Autor:
James S. H. Wong, Mohammadali Nikoo, Jean N. Westenberg, Janet G. Suen, Jennifer Y. C. Wong, Reinhard M. Krausz, Christian G. Schütz, Marc Vogel, Jesse A. Sidhu, Jessica Moe, Shane Arishenkoff, Donald Griesdale, Nickie Mathew, Pouya Azar
Publikováno v:
Addiction Science & Clinical Practice, Vol 16, Iss 1, Pp 1-10 (2021)
Abstract Background Buprenorphine/naloxone (Suboxone) is a current first-line treatment for opioid use disorder (OUD). The standard induction method of buprenorphine/naloxone requires patients to be abstinent from opioids and therefore experience wit
Externí odkaz:
https://doaj.org/article/f8edda90e3b64dd1b3a9334a2ff5dc08
Autor:
Jennifer Rozylo, Keren Mitchell, Mohammadali Nikoo, S. Elise Durante, Skye P. Barbic, Daniel Lin, Steve Mathias, Pouya Azar
Publikováno v:
Addiction Science & Clinical Practice, Vol 15, Iss 1, Pp 1-6 (2020)
Abstract Background The requirement for moderate withdrawal prior to initiation can be a barrier to buprenorphine/naloxone induction. Case presentation We aimed to use a microdosing regimen to initiate regular dosing of buprenorphine/naloxone in a hi
Externí odkaz:
https://doaj.org/article/42522561508c4de4bc551d2e3a27946b
Autor:
Raman Sandhu, Rebecca Zivanovic, Sukhpreet Klaire, Mohammadali Nikoo, Jennifer Rozylo, Pouya Azar
Publikováno v:
Canadian Journal of Pain, Vol 3, Iss 1, Pp 79-84 (2019)
Background Due to its unique pharmacologic properties, efficacy as an analgesic, and role as a first-line medication for the treatment of opioid use disorder, sublingual buprenorphine has emerged as a treatment for patients with concurrent chronic pa
Externí odkaz:
https://doaj.org/article/9e7c9d627be04237b0faf4c23bb43051
Autor:
Skye P. Barbic, Adelena Leon, Ian Manion, Sarah Irving, Rebecca Zivanovic, Emily Jenkins, Shelly Ben-David, Pouya Azar, Amy Salmon, Carolyn Helps, Stephanie Gillingham, Tara Beaulieu, Rachal Pattison, Corinne Talon, Oluseyi Oyedele, Karen Tee, Steve Mathias
Publikováno v:
International Journal of Mental Health Systems, Vol 13, Iss 1, Pp 1-8 (2019)
Abstract Background While considerable progress is being made to understand the health and self-management needs of youth with mental health disorders, little attention has focused on the mental health and recovery needs that the youth themselves ide
Externí odkaz:
https://doaj.org/article/908789d8d26f463982e5a0ca0b7ffdd5
Autor:
Michael Krausz, Jean N. Westenberg, Vivian Tsang, Janet Suen, Martha J. Ignaszewski, Nickie Mathew, Pouya Azar, Maurice Cabanis, Julie Elsner, Marc Vogel, Renske Spijkerman, Laura Orsolini, Dzung Vo, Eva Moore, Jessica Moe, Johannes Strasser, Patrick Köck, Calin Marian, Kenneth M. Dürsteler, Markus Backmund, Jeanette Röhrig, Marianne Post, Hans Haltmayer, Wolfgang Wladika, Thomas Trabi, Christian Muller, Gerhard Rechberger, Maree Teesson, Michael Farrell, Grant Christie, Sally Merry, Mostafa Mamdouh, Rachel Alinsky, Sharon Levy, Marc Fishman, Richard Rosenthal, Kerry Jang, Fiona Choi
Publikováno v:
Medicina, Vol 58, Iss 4, p 539 (2022)
Background and Objectives: Now more than ever, there is an obvious need to reduce the overall burden of disease and risk of premature mortality that are associated with mental health and substance use disorders among young people. However, the curren
Externí odkaz:
https://doaj.org/article/266403c39f564631814c0fca70508fcb
Publikováno v:
Annals of Emergency Medicine. 80:509-524
Buprenorphine induction for treating opioid use disorder is being implemented in emergency care. During this era of high-potency synthetic opioid use, novel and divergent algorithms for buprenorphine induction are emerging to optimize induction exper
Autor:
Pouya Azar, James S.H. Wong, Nickie Mathew, Marc Vogel, Jeanmarie Perrone, Andrew A. Herring, Reinhard M. Krausz, Julio S.G. Montaner, Mark K. Greenwald, Anil R. Maharaj
Publikováno v:
Journal of Addiction Medicine. 17:233-236
Buprenorphine is an effective medication for the treatment of opioid use disorder. However, the traditional method of buprenorphine induction requires a period of abstinence and the development of at least moderate withdrawal, which can be barriers i